Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-312025-03-31The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.true2024-04-01falseNo description of principal activity11truefalse 09747342 2024-04-01 2025-03-31 09747342 2023-04-01 2024-03-31 09747342 2025-03-31 09747342 2024-03-31 09747342 c:Director1 2024-04-01 2025-03-31 09747342 d:OfficeEquipment 2024-04-01 2025-03-31 09747342 d:OfficeEquipment 2025-03-31 09747342 d:OfficeEquipment 2024-03-31 09747342 d:OtherPropertyPlantEquipment 2024-04-01 2025-03-31 09747342 d:OtherPropertyPlantEquipment 2025-03-31 09747342 d:OtherPropertyPlantEquipment 2024-03-31 09747342 d:CurrentFinancialInstruments 2025-03-31 09747342 d:CurrentFinancialInstruments 2024-03-31 09747342 d:Non-currentFinancialInstruments 2025-03-31 09747342 d:Non-currentFinancialInstruments 2024-03-31 09747342 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-31 09747342 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-31 09747342 d:Non-currentFinancialInstruments d:AfterOneYear 2025-03-31 09747342 d:Non-currentFinancialInstruments d:AfterOneYear 2024-03-31 09747342 d:ShareCapital 2025-03-31 09747342 d:ShareCapital 2024-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2025-03-31 09747342 d:RetainedEarningsAccumulatedLosses 2024-03-31 09747342 c:OrdinaryShareClass1 2024-04-01 2025-03-31 09747342 c:OrdinaryShareClass1 2025-03-31 09747342 c:OrdinaryShareClass1 2024-03-31 09747342 c:FRS102 2024-04-01 2025-03-31 09747342 c:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 09747342 c:FullAccounts 2024-04-01 2025-03-31 09747342 c:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 09747342 e:PoundSterling 2024-04-01 2025-03-31 iso4217:GBP xbrli:shares xbrli:pure
Registered number: 09747342



EXECUTIVE HEALTH CONTROL LIMITED


UNAUDITED
FINANCIAL STATEMENTS
INFORMATION FOR FILING WITH THE REGISTRAR
FOR THE YEAR ENDED 31 MARCH 2025

 
EXECUTIVE HEALTH CONTROL LIMITED
REGISTERED NUMBER: 09747342

STATEMENT OF FINANCIAL POSITION
AS AT 31 MARCH 2025

2025
2024
Note
£
£

  

Current assets
  

Cash at bank and in hand
 5 
382
538

  
382
538

Creditors: amounts falling due within one year
 6 
(1,200)
(1,200)

Net current liabilities
  
 
 
(818)
 
 
(662)

Total assets less current liabilities
  
(818)
(662)

Creditors: amounts falling due after more than one year
 7 
(89,393)
(88,167)

  

Net liabilities
  
(90,211)
(88,829)


Capital and reserves
  

Called up share capital 
 8 
100
100

Profit and loss account
 9 
(90,311)
(88,929)

  
(90,211)
(88,829)


The director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of income and retained earnings in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf by: 



Ryan Lukas Farhad
Director

Date: 5 December 2025
Page 1

 
EXECUTIVE HEALTH CONTROL LIMITED
REGISTERED NUMBER: 09747342
    
STATEMENT OF FINANCIAL POSITION (CONTINUED)
AS AT 31 MARCH 2025


The notes on pages 3 to 6 form part of these financial statements.

Page 2

 
EXECUTIVE HEALTH CONTROL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies

 
1.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
1.2

Revenue

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes. The following criteria must also be met before revenue is recognised:

Rendering of services

Revenue from a contract to provide services is recognised in the period in which the services are provided in accordance with the stage of completion of the contract when all of the following conditions are satisfied:
the amount of revenue can be measured reliably;
it is probable that the Company will receive the consideration due under the contract;
the stage of completion of the contract at the end of the reporting period can be measured reliably; and
the costs incurred and the costs to complete the contract can be measured reliably.

 
1.3

Borrowing costs

All borrowing costs are recognised in profit or loss in the year in which they are incurred.

Page 3

 
EXECUTIVE HEALTH CONTROL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

1.Accounting policies (continued)

 
1.4

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
33%
Straight line
Other fixed assets
-
33%
Straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

 
1.5

Cash and cash equivalents

Cash is represented by cash in hand and deposits with financial institutions repayable without penalty on notice of not more than 24 hours. Cash equivalents are highly liquid investments that mature in no more than three months from the date of acquisition and that are readily convertible to known amounts of cash with insignificant risk of change in value.

 
1.6

Creditors

Short-term creditors are measured at the transaction price. Other financial liabilities, including bank loans, are measured initially at fair value, net of transaction costs, and are measured subsequently at amortised cost using the effective interest method.

Page 4

 
EXECUTIVE HEALTH CONTROL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

2.


Judgments in applying accounting policies and key sources of estimation uncertainty

In the application of the company's accounting policies management is required to make judgements, estimates and assumptions about the carrying value of assets and liabilities that are not readily ascertainable from other sources. The estimates and underlying assumptions are based on historical experience and other factors that are considered to be relevant. Actual outcomes may differ from these estimates.
The estimates and underlying assumptions are reviewed on a continuing basis. Revisions to accounting estimates are recognised in the period in which the estimates are revised.
The key areas of estimation uncertainty that have a significant effect on the amounts recognised in the financial statements are described below:
Accrued Expenditure
The company includes a provision for invoices which are yet to be received from and amounts paid in advance to suppliers. These provisions are estimated based upon the expected values of the invoices which are issued and services received following the period end.


3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).


4.


Tangible fixed assets





Office equipment
Other fixed assets
Total

£
£
£



Cost or valuation


At 1 April 2024
4,360
4,641
9,001



At 31 March 2025

4,360
4,641
9,001



Depreciation


At 1 April 2024
4,360
4,641
9,001



At 31 March 2025

4,360
4,641
9,001



Net book value



At 31 March 2025
-
-
-



At 31 March 2024
-
-
-

Page 5

 
EXECUTIVE HEALTH CONTROL LIMITED
 
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025

5.


Cash and cash equivalents

2025
2024
£
£

Cash at bank and in hand
382
538

382
538



6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Accruals and deferred income
1,200
1,200

1,200
1,200



7.


Creditors: Amounts falling due after more than one year

2025
2024
£
£

Director's loan account
89,393
88,167

89,393
88,167



8.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



100 (2024 - 100) Ordinary shares of £1.00 each
100
100



9.


Reserves

Profit and loss account

The profit and loss reserve is fully distributable.


10.


Related party transactions

At the balance sheet date £89,393 (2024 - £88,167) was owed to Mr R L Farhad, the director and shareholder, by the company.

Page 6

 
EXECUTIVE HEALTH CONTROL LIMITED
 
 
THIS SCHEDULE IS NOT FOR PUBLICATION Page 7